Table 1.
Demographic and Clinical Characteristics of Participants in Each Treatment Group
| CBT (N = 16) | SSRI (N = 11) | Statistic | |
|---|---|---|---|
| M (SD) | M (SD) | t | |
| Age | 11.63 (4.29) | 15.18 (2.60) | −2.45a |
| Pre-treatment anxiety severity | 25.06 (3.89) | 24.91 (4.13) | 0.10 |
| Post-treatment anxiety severity | 11.45 (6.97) | 11.26 (4.75) | 0.08 |
| Pre-treatment depressive symptoms | 11.19 (6.81) | 16.45 (6.73) | −1.98 |
| Post-treatment depressive symptoms | 7.62 (6.47) | 8.45 (5.94) | −0.34 |
| N (%) | N (%) | χ2 | |
|---|---|---|---|
| Male | 9 (56.3) | 7 (63.6) | 0.15 |
| SAD diagnosis | 6 (37.5) | 8 (72.7) | 3.24 |
| GAD diagnosis | 13 (81.3) | 7 (63.6) | 1.05 |
| Lifetime depression diagnosis | 3 (18.8) | 4 (36.6) | 1.05 |
| ADHD diagnosis | 4 (25.0) | 1 (9.1) | 1.09 |
| Separation anxiety diagnosis | 1 (6.3) | 0 (0.0) | 0.71 |
| Panic disorder diagnosis | 2 (12.5) | 0 (0.0) | 1.49 |
| Specific phobia diagnosis | 4 (25.0) | 3 (27.3) | 0.02 |
a
p < 0.05.
ADHD, attention-deficit/hyperactivity disorder; CBT, cognitive behavior therapy; GAD, generalized anxiety disorder; SAD, social anxiety disorder; SSRI, selective serotonin reuptake inhibitor.